COPD Causes


Main COPD Causes

Chronic obstructive pulmonary disorder, or COPD, has several known causes. In general terms, the condition is the direct result of severe, long-term irritation to the lungs and airways. This can lead to scarring, irritation and a gradual loss of lung function.

COPD causes that can contribute to this type of long-term irritation include:

  • Tobacco use or exposure to secondhand smoke – Smoking is one of the most common COPD causes. Tobacco products contain hundreds of chemicals, including acetone (a common ingredient in nail polish remover), arsenic (a pest killer) and carbon monoxide (a lethal fume released in car exhaust). When these chemicals are inhaled, they can impede the lungs’ ability to clear mucus from the airways, increasing the likelihood of infection and chronic irritation.
  • Exposure to toxic chemicals and dusts – Repeated, high-dose exposure to industrial chemicals and dusts (e.g., silica dust, coal dust and welding fumes) can cause COPD. This is one reason that the incidence of the condition is especially high in miners, welders, petroleum workers and concrete manufacturers. Environmental exposure to air pollutants in industrial and urban environments (e.g., areas near fossil fuel plants) can also increase a person’s likelihood of developing the condition.
  • Alpha-1-antitrypsin deficiency – In this genetic condition, the lungs do not produce alpha-1-antitrypsin, a protein that protects against the damaging effects of certain enzymes. However, alpha-1-antitrypsin deficiency causes just 1 percent of all COPD diagnoses.

As the medical community strives to learn more about COPD causes, researchers are also investigating newer and more promising ways to treat the condition. One of these options is stem cell therapy, which is offered at the Lung Institute. Using a patient’s own stem cells to help reduce inflammation, alleviate symptoms and possibly even slow the progression of the disease, this alternative treatment has helped many individuals improve their quality of life following a COPD diagnosis.

While COPD causes a significant change to a person’s health, living a full life with the condition is not out of the question. If you have been diagnosed with COPD, contact the Lung Institute today and we’ll be happy to provide additional information on our stem cell therapy procedures and how they may be able to improve your situation. Our dedicated team can be reached at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.